Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Cancer Gene Therapy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Cancer Gene Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Cancer Gene Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Celgene
GlaxoSmithKline
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
Bluebird bio, Inc
BioCancell
SynerGene Therapeutics
OncoGenex Pharmaceuticals
Adaptimmune
Merck
By Type:
Ex-vivo
In-vivo
By End-User:
Biopharma Companies
Research Institutes
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Cancer Gene Therapy Market
-
1.3 Market Segment by Type
-
1.3.1 USA Cancer Gene Therapy Market Size and Growth Rate of Ex-vivo from 2016 to 2027
-
1.3.2 USA Cancer Gene Therapy Market Size and Growth Rate of In-vivo from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Cancer Gene Therapy Market Size and Growth Rate of Biopharma Companies from 2016 to 2027
-
1.4.2 USA Cancer Gene Therapy Market Size and Growth Rate of Research Institutes from 2016 to 2027
-
1.4.3 USA Cancer Gene Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Cancer Gene Therapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Cancer Gene Therapy by Major Types
-
3.4.1 Market Size and Growth Rate of Ex-vivo
-
3.4.2 Market Size and Growth Rate of In-vivo
4 Segmentation of Cancer Gene Therapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Cancer Gene Therapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of Cancer Gene Therapy in Biopharma Companies
-
4.4.2 Market Size and Growth Rate of Cancer Gene Therapy in Research Institutes
-
4.4.3 Market Size and Growth Rate of Cancer Gene Therapy in Others
5 Market Analysis by Regions
-
5.1 USA Cancer Gene Therapy Production Analysis by Regions
-
5.2 USA Cancer Gene Therapy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Cancer Gene Therapy Landscape Analysis
-
6.1 West USA Cancer Gene Therapy Landscape Analysis by Major Types
-
6.2 West USA Cancer Gene Therapy Landscape Analysis by Major End-Users
7 South USA Cancer Gene Therapy Landscape Analysis
-
7.1 South USA Cancer Gene Therapy Landscape Analysis by Major Types
-
7.2 South USA Cancer Gene Therapy Landscape Analysis by Major End-Users
8 Middle West USA Cancer Gene Therapy Landscape Analysis
-
8.1 Middle West USA Cancer Gene Therapy Landscape Analysis by Major Types
-
8.2 Middle West USA Cancer Gene Therapy Landscape Analysis by Major End-Users
9 Northeast USA Cancer Gene Therapy Landscape Analysis
-
9.1 Northeast USA Cancer Gene Therapy Landscape Analysis by Major Types
-
9.2 Northeast USA Cancer Gene Therapy Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Celgene
-
10.1.1 Celgene Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 GlaxoSmithKline
-
10.2.1 GlaxoSmithKline Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Shanghai Sunway Biotech
-
10.3.1 Shanghai Sunway Biotech Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Shenzhen SiBiono GeneTech
-
10.4.1 Shenzhen SiBiono GeneTech Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Bluebird bio, Inc
-
10.5.1 Bluebird bio, Inc Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 BioCancell
-
10.6.1 BioCancell Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 SynerGene Therapeutics
-
10.7.1 SynerGene Therapeutics Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 OncoGenex Pharmaceuticals
-
10.8.1 OncoGenex Pharmaceuticals Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Adaptimmune
-
10.9.1 Adaptimmune Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Merck
-
10.10.1 Merck Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Cancer Gene Therapy Market Size and Growth Rate of Ex-vivo from 2016 to 2027
-
Figure USA Cancer Gene Therapy Market Size and Growth Rate of In-vivo from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Cancer Gene Therapy Market Size and Growth Rate of Biopharma Companies from 2016 to 2027
-
Figure USA Cancer Gene Therapy Market Size and Growth Rate of Research Institutes from 2016 to 2027
-
Figure USA Cancer Gene Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Cancer Gene Therapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Cancer Gene Therapy
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Cancer Gene Therapy by Different Types from 2016 to 2027
-
Table Consumption Share of Cancer Gene Therapy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Ex-vivo
-
Figure Market Size and Growth Rate of In-vivo
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Cancer Gene Therapy by Different End-Users from 2016 to 2027
-
Table Consumption Share of Cancer Gene Therapy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Biopharma Companies
-
Figure Market Size and Growth Rate of Research Institutes
-
Figure Market Size and Growth Rate of Others
-
Table USA Cancer Gene Therapy Production by Regions
-
Table USA Cancer Gene Therapy Production Share by Regions
-
Figure USA Cancer Gene Therapy Production Share by Regions in 2016
-
Figure USA Cancer Gene Therapy Production Share by Regions in 2021
-
Figure USA Cancer Gene Therapy Production Share by Regions in 2027
-
Table USA Cancer Gene Therapy Consumption by Regions
-
Table USA Cancer Gene Therapy Consumption Share by Regions
-
Figure USA Cancer Gene Therapy Consumption Share by Regions in 2016
-
Figure USA Cancer Gene Therapy Consumption Share by Regions in 2021
-
Figure USA Cancer Gene Therapy Consumption Share by Regions in 2027
-
Table West USA Cancer Gene Therapy Consumption by Types from 2016 to 2027
-
Table West USA Cancer Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure West USA Cancer Gene Therapy Consumption Share by Types in 2016
-
Figure West USA Cancer Gene Therapy Consumption Share by Types in 2021
-
Figure West USA Cancer Gene Therapy Consumption Share by Types in 2027
-
Table West USA Cancer Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table West USA Cancer Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Cancer Gene Therapy Consumption Share by End-Users in 2016
-
Figure West USA Cancer Gene Therapy Consumption Share by End-Users in 2021
-
Figure West USA Cancer Gene Therapy Consumption Share by End-Users in 2027
-
Table South USA Cancer Gene Therapy Consumption by Types from 2016 to 2027
-
Table South USA Cancer Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure South USA Cancer Gene Therapy Consumption Share by Types in 2016
-
Figure South USA Cancer Gene Therapy Consumption Share by Types in 2021
-
Figure South USA Cancer Gene Therapy Consumption Share by Types in 2027
-
Table South USA Cancer Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table South USA Cancer Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Cancer Gene Therapy Consumption Share by End-Users in 2016
-
Figure South USA Cancer Gene Therapy Consumption Share by End-Users in 2021
-
Figure South USA Cancer Gene Therapy Consumption Share by End-Users in 2027
-
Table Middle West USA Cancer Gene Therapy Consumption by Types from 2016 to 2027
-
Table Middle West USA Cancer Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Cancer Gene Therapy Consumption Share by Types in 2016
-
Figure Middle West USA Cancer Gene Therapy Consumption Share by Types in 2021
-
Figure Middle West USA Cancer Gene Therapy Consumption Share by Types in 2027
-
Table Middle West USA Cancer Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Cancer Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Cancer Gene Therapy Consumption Share by End-Users in 2016
-
Figure Middle West USA Cancer Gene Therapy Consumption Share by End-Users in 2021
-
Figure Middle West USA Cancer Gene Therapy Consumption Share by End-Users in 2027
-
Table Northeast USA Cancer Gene Therapy Consumption by Types from 2016 to 2027
-
Table Northeast USA Cancer Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Cancer Gene Therapy Consumption Share by Types in 2016
-
Figure Northeast USA Cancer Gene Therapy Consumption Share by Types in 2021
-
Figure Northeast USA Cancer Gene Therapy Consumption Share by Types in 2027
-
Table Northeast USA Cancer Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Cancer Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Cancer Gene Therapy Consumption Share by End-Users in 2016
-
Figure Northeast USA Cancer Gene Therapy Consumption Share by End-Users in 2021
-
Figure Northeast USA Cancer Gene Therapy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Celgene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene
-
Figure Sales and Growth Rate Analysis of Celgene
-
Figure Revenue and Market Share Analysis of Celgene
-
Table Product and Service Introduction of Celgene
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Shanghai Sunway Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Sunway Biotech
-
Figure Sales and Growth Rate Analysis of Shanghai Sunway Biotech
-
Figure Revenue and Market Share Analysis of Shanghai Sunway Biotech
-
Table Product and Service Introduction of Shanghai Sunway Biotech
-
Table Company Profile and Development Status of Shenzhen SiBiono GeneTech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shenzhen SiBiono GeneTech
-
Figure Sales and Growth Rate Analysis of Shenzhen SiBiono GeneTech
-
Figure Revenue and Market Share Analysis of Shenzhen SiBiono GeneTech
-
Table Product and Service Introduction of Shenzhen SiBiono GeneTech
-
Table Company Profile and Development Status of Bluebird bio, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bluebird bio, Inc
-
Figure Sales and Growth Rate Analysis of Bluebird bio, Inc
-
Figure Revenue and Market Share Analysis of Bluebird bio, Inc
-
Table Product and Service Introduction of Bluebird bio, Inc
-
Table Company Profile and Development Status of BioCancell
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCancell
-
Figure Sales and Growth Rate Analysis of BioCancell
-
Figure Revenue and Market Share Analysis of BioCancell
-
Table Product and Service Introduction of BioCancell
-
Table Company Profile and Development Status of SynerGene Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SynerGene Therapeutics
-
Figure Sales and Growth Rate Analysis of SynerGene Therapeutics
-
Figure Revenue and Market Share Analysis of SynerGene Therapeutics
-
Table Product and Service Introduction of SynerGene Therapeutics
-
Table Company Profile and Development Status of OncoGenex Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of OncoGenex Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of OncoGenex Pharmaceuticals
-
Figure Revenue and Market Share Analysis of OncoGenex Pharmaceuticals
-
Table Product and Service Introduction of OncoGenex Pharmaceuticals
-
Table Company Profile and Development Status of Adaptimmune
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adaptimmune
-
Figure Sales and Growth Rate Analysis of Adaptimmune
-
Figure Revenue and Market Share Analysis of Adaptimmune
-
Table Product and Service Introduction of Adaptimmune
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
